A new editorial paper titled "Combined targeting of HEDGEHOG signaling and BRD4 as a novel therapeutic option against melanoma" has been published in Oncotarget.
Jul 19, 2023
0
1
Neuroblastoma is a rare form of malignant tumor, primarily affecting children under the age of six. A research team led by molecular pathologist Lukas Kenner from MedUni Vienna's Department of Pathology has now discovered, ...
Dec 3, 2019
0
4
Mayo Clinic researchers have found a way to detect and eliminate potentially troublemaking stem cells to make stem cell therapy safer. Induced Pluripotent Stem cells, also known as iPS cells, are bioengineered from adult ...
Sep 27, 2012
0
0
Despite previous data showing beneficial effects, the probiotic Saccharomuces boulardii (S. boulardii) does not prevent clinical relapse in patients with Crohn's disease, according to a new study in Clinical Gastroenterology ...
Aug 14, 2013
0
0
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.
May 21, 2013
0
0
(HealthDay)—Percutaneous bleomycin injections are effective and tolerable for the treatment of vascular malformations, according to a study published online Sept. 4 in the International Journal of Dermatology.
Sep 23, 2017
0
0
A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to new research published in the February issue of The Journal ...
Feb 8, 2021
0
8
(HealthDay)—For patients with alopecia areata (AA), superficial hypothermic cryotherapy is effective, especially when the treatment interval is two weeks or less, according to research published online Oct. 6 in the Journal ...
Oct 12, 2016
0
0
Winner of the William H. Sweet Young Investigators Award, Frank William Petraglia III, presented his research on the relationship between the efficacy of spinal cord stimulation (SCS) to block pains signals and the amount ...
May 11, 2015
0
4
Researchers at The Scripps Research Institute (TRSI) are fueling the future of cancer treatment by improving a powerful tool in disease defense: the body's immune system. By revealing a novel but widespread cell signaling ...
Nov 27, 2012
0
0
